ERBB2 and ductal breast carcinoma in situ: No staining was visible after the protein competition, indicating that the more robust Her2 staining seen in BHP-fixed DCIS breast tissue is specific and not due to secondary antibody reactivity or non-specific interactions (Figure S2).